Lung exposure to lipopolysaccharide causes atherosclerotic plaque destabilisation

European Respiratory Journal

Volumn 48, Issue 1, 2016, Pages 205-215

  Jaw, Jen Erh ^a   Tsuruta, Masashi ^a,b   Oh, Yeni ^a   Schipilow, John ^a   Hirano, Yuki ^a,b   Ngan, David A ^a   Suda, Koichi ^a,c   Li, Yuexin ^a   Oh, Jin Young ^a,d   Moritani, Konosuke ^a,b   Tam, Sheena ^a   Ford, Nancy ^a   Van Eeden, Stephan ^a   Wright, Joanne L ^a   Man, S F Paul ^a   Sin, Don D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b KEIO UNIVERSITY   (Japan)

^c FUJITA HEALTH UNIVERSITY   (Japan)

^d Dongguk University Ilsan Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; LIPOPOLYSACCHARIDE; SODIUM CHLORIDE; CYTOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; BRACHIOCEPHALIC TRUNK; CONTROLLED STUDY; EXPOSURE; HISTOLOGY; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OPTICAL PROJECTION TOMOGRAPHY; OPTICAL TOMOGRAPHY; PNEUMONIA; PRIORITY JOURNAL; WESTERN DIET; ANIMAL; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; GENETICS; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY;

ANIMALS; APOLIPOPROTEINS E; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHILS; PLAQUE, ATHEROSCLEROTIC; TOMOGRAPHY, OPTICAL;

EID: 84977110598     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00972-2015     Document Type: Article

References (31)

1. Van Eeden S, Leipsic J, Paul Man SF, et al. The relationship between lung inflammation and cardiovascular disease. Am J Respir Crit Care Med 2012; 186: 11-16.
2. Smeeth L, Thomas SL, Hall AJ, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004; 351: 2611-2618.
3. Clayton TC, Capps NE, Stephens NG, et al. Recent respiratory infection and the risk of myocardial infarction. Heart 2005; 91: 1601-1602.
4. Ramirez J, Aliberti S, Mirsaeidi M, et al. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia. Clin Infect Dis 2008; 47: 182-187.
5. Pope CA 3rd, Muhlestein JB, May HT, et al. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation 2006; 114: 2443-2448.
6. Simkhovich BZ, Kleinman MT, Kloner RA. Particulate air pollution and coronary heart disease. Curr Opin Cardiol 2009; 24: 604-609.
7. Madjid M, Miller CC, Zarubaev VV, et al. Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects. Eur Heart J 2007; 28: 1205-1210.
8. Johnson J, Carson K, Williams H, et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005; 111: 1422-1430.
9. Suda K, Eom J, Jaw JE, et al. Endotoxin-induced cardiovascular dysfunction in mice: effect of simvastatin. J Appl Physiol 2011; 111: 1118-1124.
10. Suda K, Tsuruta M, Eom J, et al. Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol 2011; 45: 510-516.
11. Daley JM, Thomay AA, Connolly MD, et al. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol 2008; 83: 64-70.
12. Sugino K, Dohi K, Yamada K, et al. The role of lipid peroxidation in endotoxin-induced hepatic damage and the protective effect of antioxidants. Surgery 1987; 101: 746-752.
13. Sharpe J, Ahlgren U, Perry P, et al. Optical projection tomography as a tool for 3D microscopy and gene expression studies. Science 2002; 296: 541-545.
14. Kirkby NS, Low L, Seckl JR, et al. Quantitative 3-dimensional imaging of murine neointimal and atherosclerotic lesions by optical projection tomography. PLoS One 2011; 6: e16906.
15. Hu JH, Du L, Chu T, et al. Overexpression of urokinase by plaque macrophages causes histological features of plaque rupture and increases vascular matrix metalloproteinase activity in aged apolipoprotein E-null mice. Circulation 2010; 121: 1637-1644.
16. Sze MA, Tsuruta M, Yang SW, et al. Changes in the bacterial microbiota in gut, blood, and lungs following acute LPS instillation into mice lungs. PLoS One 2014; 9: e111228.
17. Buffon A, Biasucci LM, Liuzzo G, et al. Widespread coronary inflammation in unstable angina. N Engl J Med 2002; 347: 5-12.
18. Chen YC, Bui AV, Diesch J, et al. A novel mouse model of atherosclerotic plaque instability for drug testing and mechanistic/therapeutic discoveries using gene and microRNA expression profiling. Circ Res 2013; 113: 252-265.
19. Silvestre-Roig C, de Winther MP, Weber C, et al. Atherosclerotic plaque destabilisation: mechanisms, models, and therapeutic strategies. Circ Res 2014; 114: 214-226.
20. Brennan ML, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003; 349: 1595-1604.
21. Malle E, Furtmüller PG, Sattler W, et al. Myeloperoxidase: a target for new drug development? Br J Pharmacol 2007; 152: 838-854.
22. Eiserich JP, Baldus S, Brennan ML, et al. Myeloperoxidase, a leukocyte-derived vascular NO oxidase. Science 2002; 296: 2391-2394.
23. Hazen SL. Myeloperoxidase and plaque vulnerability. Arterioscler Thromb Vasc Biol 2004; 24: 1143-1146.
24. Fu X, Kassim SY, Parks WC, et al. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J Biol Chem 2001; 276: 41279-41287.
25. Weiss SJ, Peppin G, Ortiz X, et al. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985; 227: 747-749.
26. Gough PJ, Gomez IG, Wille PT, et al. Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice. J Clin Invest 2006; 116: 59-69.
27. Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J Am Coll Cardiol 2010; 55: 1102-1109.
28. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 2003; 108: 1440-1445.
29. Ferrante G, Nakano M, Prati F, et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation 2010; 122: 2505-2513.
30. Kutter D, Devaquet P, Vanderstocken G, et al. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol 2000; 104: 10-15.
31. Matoba T, Sato K, Egashira K. Mouse models of plaque rupture. Curr Opin Lipidol 2013; 24: 419-425.